Moreover, we demonstrated the relationship between FERMT1 expression and DNA methylation, N6-methyladenosine (m6A) modification, immune infiltration and the sensitivity of PAAD patients to chemotherapy drugs. The gene discussed is FERMT1; the disease is pancreatic adenocarcinoma.